13.2605.42% ( -0.760 )
Delay Closed: Nov 20, 16:08:00Wiki
About
The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Hang Seng Hong Kong-Listed Biotech Index.
- Name
- CAM HSBIOTECH
- Index tracked
- Hang Seng HK-Listed Biotech TR HKD
- Type
- Equity
- Expense ratio
- --
- Management fee
- 0.5%
- Dividend policy
- Annually
- NAV
- HKD 14.0165 (11/18/2026)
- Issued units
- 258.20M (11/19/2026)
- Listing date
- Mar 17, 2021
- Sponsor
- China Asset Management (HK) Limited
- Custodian
- --
ETF Documents
Last updatedType
05/21/2026Annual Report
09/10/2026Semi Annual Report
10/30/2026Prospectus
10/20/2026Factsheet
